Polymorphism rs564398 of the ANRIL Gene as a Coronary-Artery-Disease-Associated SNP in Diabetic Patients of the Kazakh Population
Aitkaliyev A. Bekenova N. Vochshenkova T. Kassiyeva B. Benberin V.
November 2024Multidisciplinary Digital Publishing Institute (MDPI)
Diagnostics
2024#14Issue 21
Background/Objectives. A cardiovascular complication of type 2 diabetes mellitus like coronary artery disease is influenced by a complex interplay between environmental, phenotypic, and genetic factors. The genetic mechanisms in the development of this pathology are not established. This study aims to evaluate the association of polymorphisms rs1011970, rs62560775, and rs564398 from the 9p21.3 locus with coronary artery disease in diabetic patients of the Kazakh population. Methods. A total of 343 people participated in the case-control study: the control group consisted of 109 people with type 2 diabetes and coronary artery disease, while the control group included 234 people. Genotyping was performed using real-time PCR. Statistical analysis was carried out using Chi-square methods and calculating odds ratios (OR) with 95% confidence intervals (CI). Results. According to the results, only the rs564398 polymorphism of the ANRIL gene was associated with coronary artery disease (p = 0.04). The CC genotype increased the risk of developing coronary artery disease by more than 1.5 times (1.62 (1.02–2.56)), whereas the TT genotype reduced the risk of coronary artery disease (0.39 (0.17–0.91)). The remaining polymorphisms, rs1011970 and rs62560775, were not associated with coronary artery disease. Conclusions. Thus, this research further elicits the association of the ANRIL gene with cardiometabolic disease.
ANRIL gene , coronary artery disease , polymorphism rs564398
Text of the article Перейти на текст статьи
Department of Science, Medical Centre Hospital of President’s Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana, 010000, Kazakhstan
Institute of Innovative and Preventive Medicine, Alikhan Bokeikhan Street, Building 1, Astana, 010000, Kazakhstan
Department of Science
Institute of Innovative and Preventive Medicine
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026